Activin and Inhibin

EPZ020411 is a selective inhibitor of PRMT6 with an IC 50 of 10 nM, has &gt:10 folds selectivity for PRMT6 over PRMT1 and PRMT8 . EPZ020411 can be used for the research of cancerIn VitroEPZ020411 (0-20 μM: 24 h) decreases H3R2 methylation in A375

an estrogenic steroid that is usually found in pregnant horses.

Erastin2 is a ferroptosis inducer and a potent, selective inhibitor of the system xc(-) cystine/glutamate transporter.Form:Solid.

Erastin2 is a ferroptosis inducer and a potent, selective inhibitor of the system xc(-) cystine/glutamate transporter.Form:Solid.

Erastin2 is a ferroptosis inducer and a potent, selective inhibitor of the system xc(-) cystine/glutamate transporter.Form:Solid.

Erastin2 is a ferroptosis inducer and a potent, selective inhibitor of the system xc(-) cystine/glutamate transporter.Form:Solid.

Erastin2 is a ferroptosis inducer and a potent, selective inhibitor of the system xc(-) cystine/glutamate transporter.Form:Solid.

ERB-196 is a nonsteroidal selective estrogen receptor-β ( ERβ ) agonist.In VivoERB-196 is a nonsteroidal selective estrogen receptor-β (ERβ) agonist. ERB-196 significantly reduces histopathologic evidence of injury to the gastrointestinal mucosal

ERB-196 is a nonsteroidal selective estrogen receptor-β ( ERβ ) agonist.In VivoERB-196 is a nonsteroidal selective estrogen receptor-β (ERβ) agonist. ERB-196 significantly reduces histopathologic evidence of injury to the gastrointestinal mucosal

ERCC1-XPF-IN-2 is a potent ERCC1-XPF endonuclease inhibitor with an IC 50 value of 0.6 µM. ERCC1-XPF-IN-2 shows activity in nucleotide excision repair, cisplatin enhancement and γH2AX assaysIn VitroERCC1-XPF-IN-2 (compound 13) (0-100 µM) shows FEN-1

ERCC1-XPF-IN-2 is a potent ERCC1-XPF endonuclease inhibitor with an IC 50 value of 0.6 µM. ERCC1-XPF-IN-2 shows activity in nucleotide excision repair, cisplatin enhancement and γH2AX assaysIn VitroERCC1-XPF-IN-2 (compound 13) (0-100 µM) shows FEN-1

ERCC1-XPF-IN-2 is a potent ERCC1-XPF endonuclease inhibitor with an IC 50 value of 0.6 µM. ERCC1-XPF-IN-2 shows activity in nucleotide excision repair, cisplatin enhancement and γH2AX assaysIn VitroERCC1-XPF-IN-2 (compound 13) (0-100 µM) shows FEN-1